Hrt Financial LP Acurx Pharmaceuticals, Inc. Call Options Transaction History
Hrt Financial LP
- $18.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
27Shares Held
1.28MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$460,5330.0% of portfolio
-
Prospect Financial Services LLC Melville, NY329KShares$286,2960.15% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$127,4550.0% of portfolio
-
Morgan Stanley New York, NY46.2KShares$40,1940.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC44.8KShares$38,9580.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $10.1M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...